PlainRecalls
ModerateClass IITerminated

FDA Devices recall · Reported February 5, 2020

Cyberonics VNS Therapy AspireHC Model 105 Generator, 26-0007-4000/3. The firm name on the label is CYBERONICS, INC., Houston, TX. Vagus nerve stimulator.

This recall is an expansion of Z-3019-2017 and Z-3020-2017, which was initiated to fix the devices premature battery depletion, caused by electrical leakage on the circuit board a…

Recall #
Z-0868-2020
Affected scope
106 devices
Initiated
November 16, 2018
Verify with FDA Devices →
View my saved recalls

LivaNova USA Inc recalled Cyberonics VNS Therapy AspireHC Model 105 Generator, 26-0007-4000/3. The firm name on t… — a moderate-severity action.

Cyberonics VNS Therapy AspireHC Model 105 Generator, 26-0007-4000/3. The firm name on t… was recalled by LivaNova USA Inc in February 5, 2020. Reason: This recall is an expansion of Z-3019-2017 and Z-3020-2017, which was initiated to fix the devices premature …. Check the official notice for the remedy. Verify recall #Z-0868-2020 with the FDA Devices before acting.

The recall

LivaNova USA Inc issued this moderate-severity FDA Devices recall — This recall is an expansion of Z-3019-2017 and Z-3020-2017, which was initiated to fix the devices premature ….

Moderate
severity level
106 units
affected scope
Class II
classification
February 5, 2020
reported

Sourced from official FDA Devices enforcement records. Verify recall #Z-0868-2020 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Devices action (record #Z-0868-2020) was formally reported on February 5, 2020, with the manufacturer initiating the action on November 16, 2018. It is classified under Moderate severity (Class II), with a current status of Terminated. LivaNova USA Inc is listed as the recalling firm, operating out of Houston, TX. Federal records list the affected scope as 106 devices.

The documented reason for this recall is: This recall is an expansion of Z-3019-2017 and Z-3020-2017, which was initiated to fix the devices premature battery depletion, caused by electrical leakage on the circuit board assemblies of the Models 105 and 106 gene… Distribution data in the federal record shows the product reached: Distribution US nationwide, including Puerto Rico. There was no foreign/military/government consignees.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Devices — clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Medical Devices recalls over time

Where this recall sits in its category — 40,409 medical devices recalls on record

-1,00001,0002,0003,0004,0005,000 20052008201120142017202020232026 1,243

Where this recall sits in the database

Severity2366872097High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 100,165 recalls in the database, 23,668 are high severity, 72,097 moderate, and 4,400 low. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger — we do not rank products by risk from raw recall volume.

Severity

Moderate

Affected scope

106 devices

Related Recalls

6

6 from same agency

Product description

Cyberonics VNS Therapy AspireHC Model 105 Generator, 26-0007-4000/3. The firm name on the label is CYBERONICS, INC., Houston, TX. Vagus nerve stimulator.

Reason for recall

This recall is an expansion of Z-3019-2017 and Z-3020-2017, which was initiated to fix the devices premature battery depletion, caused by electrical leakage on the circuit board assemblies of the Models 105 and 106 generators. *Note this recall occurred in November 2018.

Recall Profile

Structured summary of the FDA Devices recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Terminated
Recall number Z-0868-2020
Date reported February 5, 2020
Date initiated November 16, 2018
Recalling firm LivaNova USA Inc
Firm location Houston, TX
Affected scope 106 devices
Distribution Distribution US nationwide, including Puerto Rico. There was no foreign/military/government consignees.

Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.

Scale of Impact

106 devices units affected — limited or regional distribution scale.

Regional (<10K units) ✓ This recall
Multi-state (10K – 100K units)
Large-scale (100K – 1M units)
Massive (≥1M units)

Bracket cutoffs follow federal recall-disclosure conventions; bar widths scale linearly within each bracket. Source: PlainRecalls analysis of U.S. Food and Drug Administration filings.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (Z-0868-2020) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Devices before acting — recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Cyberonics VNS Therapy AspireHC Model 105 Generator, 26-0007-4000/3. The firm name on the label is CYBERONICS, INC., Houston, TX. Vagus nerve stimulator.. Recalled by LivaNova USA Inc. Units affected: 106 devices.
Why was this product recalled?
This recall is an expansion of Z-3019-2017 and Z-3020-2017, which was initiated to fix the devices premature battery depletion, caused by electrical leakage on the circuit board assemblies of the Models 105 and 106 generators. *Note this recall occurred in November 2018.
Which agency issued this recall?
This recall was issued by the FDA Devices on February 5, 2020. Severity: Moderate. Recall number: Z-0868-2020.
Where was the recalled product distributed?
Distribution: Distribution US nationwide, including Puerto Rico. There was no foreign/military/government consignees..
How do I check if my product is affected by a recall?
Check the product description and recall number (Z-0868-2020) against your product. Visit the official FDA Devices website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category — useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with GE HealthCare TRADE IN CARESCAPE TELEMETRY SERVER ARK-2250L… →

Data Sources

Source: FDA, CPSC, and NHTSA federal recall databases. This recall: FDA Devices, reported February 5, 2020.

  • Source: FDA — Food and Drug Administration, openFDA Enforcement API (food, drug, and medical device recalls)
  • Source: CPSC — Consumer Product Safety Commission Recalls API (consumer product recalls and hazards)
  • Source: NHTSA — National Highway Traffic Safety Administration Recalls API (vehicle safety recalls)

Recall information is sourced from official federal agency databases. Always verify recall details with the issuing agency for the most current status. This information is for research and awareness purposes only.

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records — no number is typed in by an editor. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of June 2026.